National Institute of Health (NIH) awards InfeXtious Therapeutic a Small Business Technology Transfer (STTR) grant for the development of broad-spectrum cyclic amphiphilic peptides to combat antimicrobial resistance

InfeXtious Therapeutic, a subsidiary of AJK Biopharmaceutical, is headquartered at University Lab Partners, the premier life science incubator located in UCI Research Park. IRVINE, Calif., Sept. 8, 2022 /PRNewswire/ -- InfeXtious Therapeutic announces a Small Business Technology Transfer...

Click to view original post